1 | VERV | Verve Therapeutics, Inc. | 5.48% |
2 | CPH: NSIS.B | Novozymes A/S | 2.67% |
3 | NTRA | Natera, Inc. | 2.60% |
4 | NTLA | Intellia Therapeutics, Inc. | 2.53% |
5 | CRSP | CRISPR Therapeutics AG | 2.44% |
6 | DNA | Ginkgo Bioworks Holdings, Inc. | 2.33% |
7 | TWST | Twist Bioscience Corporation | 2.24% |
8 | LLY | Eli Lilly and Company | 2.24% |
9 | AGIO | Agios Pharmaceuticals, Inc. | 1.95% |
10 | RGNX | REGENXBIO Inc. | 1.93% |
11 | SANA | Sana Biotechnology, Inc. | 1.90% |
12 | ARCT | Arcturus Therapeutics Holdings Inc. | 1.84% |
13 | GILD | Gilead Sciences, Inc. | 1.80% |
14 | TXG | 10x Genomics, Inc. | 1.77% |
15 | BEAM | Beam Therapeutics Inc. | 1.75% |
16 | BNTX | BioNTech SE | 1.70% |
17 | VCYT | Veracyte, Inc. | 1.67% |
18 | VRTX | Vertex Pharmaceuticals Incorporated | 1.66% |
19 | MRNA | Moderna, Inc. | 1.66% |
20 | SWX: NOVN | Novartis AG | 1.56% |
21 | UTHR | United Therapeutics Corporation | 1.56% |
22 | TEM | Tempus AI, Inc. | 1.52% |
23 | EDIT | Editas Medicine, Inc. | 1.50% |
24 | CTVA | Corteva, Inc. | 1.49% |
25 | AMGN | Amgen Inc. | 1.45% |
View WDNA holdings |